chr1-44831758-G-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_003738.5(PTCH2):c.565C>G(p.Leu189Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000492 in 1,586,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L189I) has been classified as Uncertain significance.
Frequency
Consequence
NM_003738.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCH2 | ENST00000372192.4 | c.565C>G | p.Leu189Val | missense_variant | Exon 5 of 22 | 1 | NM_003738.5 | ENSP00000361266.3 | ||
PTCH2 | ENST00000447098.6 | c.565C>G | p.Leu189Val | missense_variant | Exon 5 of 23 | 1 | ENSP00000389703.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000726 AC: 15AN: 206568Hom.: 0 AF XY: 0.0000718 AC XY: 8AN XY: 111394
GnomAD4 exome AF: 0.0000495 AC: 71AN: 1434582Hom.: 0 Cov.: 32 AF XY: 0.0000478 AC XY: 34AN XY: 711478
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74438
ClinVar
Submissions by phenotype
Gorlin syndrome;C0025149:Medulloblastoma;C2751544:Basal cell carcinoma, susceptibility to, 1 Uncertain:1
- -
PTCH2-related disorder Uncertain:1
The PTCH2 c.565C>G variant is predicted to result in the amino acid substitution p.Leu189Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.018% of alleles in individuals of South Asian descent in gnomAD. This variant is classified as uncertain significance in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/524558/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Gorlin syndrome Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 189 of the PTCH2 protein (p.Leu189Val). This variant is present in population databases (rs747885797, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PTCH2-related conditions. ClinVar contains an entry for this variant (Variation ID: 524558). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PTCH2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Medulloblastoma;C2751544:Basal cell carcinoma, susceptibility to, 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at